Risky trade: Infectious disease in the era of global trade

Risky Trade: Infectious Disease in the Era of Global Trade

Volumn , Issue , 2012, Pages 1-212

  Kimball, Ann Marie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84937565541     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (207)

1. Arcal, Y. and M. Maetz (2000). “Trends in world and agricultural trade”, Multilateral Trade Negotiations on Agriculture: A Resource Manual, Food and Agriculture Organization of the United Nations.
2. Ewald, P. M. (1996). Evolution of Infectious Disease, Oxford University Press.
3. Huang, S. W. (2004). “An overview of global trade patterns in fruits and vegetables”, Global Trade Patterns in Fruits and Vegetables, United States Department of Agriculture Economic Research Service.
4. Kimball, A., K. Taneda, et al. (2005, in press). “An evidence base for international health regulations: quantitative measurement of the impacts of epidemic disease on global trade”, Revue scientifique et technique.
5. Koivusalo, M. (2003). “Assessing health policy implications of WTO agreements”, Health Impacts of Globalization: Towards Global Governance, K. Lee, Palgrave Macmillan.
6. Lederberg, J., R. E. Shope, et al. (eds) (1992). Emerging Infections: Microbial Threats to Health in the United States, Institute of Medicine, National Academy Press.
7. McMichael, A. (1993). Planetary Overload: Global Environmental Change and the Health of the Human Species, Cambridge University Press.
8. UNICEF and World Health Organization (2002). Meeting the MDG Drinking Water and Sanitation Target: A Mid–term Assessment of Progress.
9. United Nations Development Programme (2002). Human Development Report 2002: Deepening Democracy in a Fragmented World.
10. Wilson, M. E. (2003). “The traveller and emerging infections: sentinel, courier, transmitter”, Journal of Applied Microbiology 94 Suppl: 1S–11S.
11. World Tourism Organization (2005). “Short–term tourism data 2004, international tourism: arrivals, receipts and expenditure”, WTO World Tourism Barometer 3(1).
12. World Trade Organization (2004). World Trade Report 2004: Trade and Trade Policy Developments.
13. World Trade Organization Committee on Sanitary and Phytosanitary Measures (2003), Summary of the meeting held on 24–25 June 2003.
14. BC Centre for Disease Control (2002). Food poisoning outbreak: Listeria Monocytogenes, soft ripened cheese, Switzerland.
15. Bell, B. P., M. Goldoft, et al. (1994). “A multistate outbreak of Escherichia coli O157:H7 – associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience”, Journal of the American Medical Association, 272(17): 1349–53.
16. Besser, R. E., P. M. Griffin, et al. (1999). “Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease”, Annual Review of Medicine 50: 355–67.
17. Calvin, L. (2003). “Produce, food safety and international trade: response to U.S. foodborne illness outbreaks associated with imported produce”, Chapter 5 in J. C. Buzby (ed.) International Trade and Food Safety: Economic Theory and Case Studies, Economic Research Service, US Department of Agriculture.
18. Centers for Disease Control and Prevention (1985). “Listeriosis outbreak associated with Mexican–style cheese – California”, MMWR Morbidity and Mortality Weekly Report 34(24): 357–9.
19. Centers for Disease Control and Prevention (1997). “Multidrug–resistant Salmonella serotype Typhimurium – United States, 1996”, MMWR Morbidity and Mortality Weekly Report 46(14): 308–10.
20. Centers for Disease Control and Prevention (2002). “Outbreak of multidrug– resistant Salmonella Newport – United States, January–April 2002”, MMWR Morbity and Mortality Weekly Report 51(25): 545–8.
21. Centers for Disease Control and Prevention (2004). “Outbreak of Salmonella serotype Enteritidis infections associated with raw almonds – United States and Canada, 2003–2004”, MMWR Morbidity and Mortality Weekly Report 53(22): 484–7.
22. Centers for Disease Control and Prevention (2005). “Escherichia coli O157:H7 infections associated with ground beef from a U.S. military installation – Okinawa, Japan, February 2004”, MMWR Morbidity and Mortality Weekly Report 54(2): 40–2.
23. Chalk, P. (2004). “The bio–terrorist threat to agricultural livestock and produce”, The Office of Science and Technology Policy Blue Ribbon Panel on the Threat of Biological Terrorism Directed Against Livestock, RAND Corporation.
24. Codex Alimentarius Commission (2002). Risk Profile for Enterohemorragic E. Coli Including the Identification of the Commodities of Concern, Including Sprouts, Ground Beef and Pork.
25. Food and Nutrition Board, Institute of Medicine, et al. (2003). Scientific Criteria to Ensure Safe Food.
26. Glynn, M. K., C. Bopp, et al. (1998). “Emergence of multidrug–resistant Salmonella enterica serotype typhimurium DT104 infections in the United States”, New England Journal of Medicine 338(19): 1333–8.
27. Gupta, A., J. Fontana, et al. (2003). “Emergence of multidrug–resistant Salmonella enterica serotype Newport infections resistant to expanded–spectrum cephalosporins in the United States”, Journal of Infectious Diseases 188(11): 1707–16.
28. Hart, M. and B. Sutton (1997). Economic Development, Food Safety, and Sustainable Export Market Access: The Case of Snow Peas from Guatemala, Guatemala, Centre for Trade Policy and Law/International Commercial Diplomacy Project.
29. Hennessy, T. W., C. W. Hedberg, et al. (1996). “A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team”, New England Journal of Medicine 334(20): 1281–6.
30. Herwaldt, B. L. (2000). “Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s”, Clinical Infectious Diseases 31(4): 1040–57.
31. Ho, A. Y., A. S. Lopez, et al. (2002). “Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000”, Emerging Infectious Diseases 8(8): 783–8.
32. Horby, P. W., S. J. O’Brien, et al. (2003). “A national outbreak of multi–resistant Salmonella enterica serovar Typhimurium definitive phage type (DT) 104 associated with consumption of lettuce”, Epidemiology and Infection 130(2): 169–78.
33. Huang, P., J. T. Weber, et al. (1995). “The first reported outbreak of diarrheal illness associated with Cyclospora in the United States”, Annals of Internal Medicine 123(6): 409–14.
34. Jones, T. F. and W. Schaffner (2003). “Salmonella in imported mangos: shoeleather and contemporary epidemiologic techniques together meet the challenge”, Clinical Infectious Diseases 37(12): 1591–2.
35. Lang, T. (1999). “Diet, health and globalization: five key questions”, Proceedings of the Nutrition Society 58(2): 335–43.
36. McLauchlin (2004). “Listeria monocytogenes and listeriosis: a review of hazard characterisation for use in microbiological risk assessment of foods”, International Journal of Food Microbiology 92(1), April: 15–33.
37. Martin, L. J., M. Fyfe, et al. (2004). “Increased burden of illness associated with antimicrobial–resistant Salmonella enterica serotype typhimurium infections”, Journal of Infectious Diseases 189(3): 377–84.
38. Ortega, Y. R., C. R. Sterling, et al. (1993). “Cyclospora species – a new protozoan pathogen of humans”, New England Journal of Medicine 328(18): 1308–12.
39. Osterholm, M. T. (1997). “Cyclosporiasis and raspberries – lessons for the future”, New England Journal of Medicine 336(22): 1597–9.
40. Ostroff, S. (1998). Testimony on the Safety of Food Imports to the Senate Committee on Governmental Affairs, US Department of Health and Human Services.
41. Powell, D. (2000). “Risk–based regulatory responses in global food trade: Guatemalan raspberry imports into the U.S. and Canada, 1996–1998”, Risk and Regulation, B. Doern, University of Toronto, pp. 131–5.
42. Riley, L. W., R. S. Remis, et al. (1983). “Hemorrhagic colitis associated with a rare Escherichia coli serotype”, New England Journal of Medicine 308(12): 681–5.
43. Ryser, E. T. and E. H. Marth (1988). “Behavior of Listeria monocytogenes during manufacture and ripening of Cheddar cheese”, Journal of Food Protection 50: 7–13.
44. Shea, K. M. (2004). “Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics”, Pediatrics 114(3): 862–8.
45. Shields, J. M. and B. H. Olson (2003). “Cyclospora cayetanensis: a review of an emerging parasitic coccidian”, International Journal of Parasitology 33(4): 371–91.
46. Sivapalasingam, S., E. Barrett, et al. (2003). “A multistate outbreak of Salmonella enterica serotype Newport infection linked to mango consumption: impact of water–dip disinfestation technology”, Clinical Infectious Diseases 37(12): 1585–90.
47. Smolinski, M. S., M. A. Hamburg, et al. (eds) (2003). Microbial Threats to Health: Emergence, Detection, and Response, Institute of Medicine.
48. State of Utah Department of Agriculture and Food (1998). Radishes, Not Beef, to Blame for 1996 Japan E. coli Outbreak.
49. Taormina, P. J., L. R. Beuchat, et al. (1999). “Infections associated with eating seed sprouts: an international concern”, Emerging Infectious Diseases 5(5): 626–34.
50. Threlfall, E. J. (2002). “Antimicrobial drug resistance in Salmonella: problems and perspectives in food– and water–borne infections”, FEMS Microbiology Reviews 26(2): 141–8.
51. US Food & Drug Administration Center for Food Safety & Applied Nutrition (2003). Quantitative Assessment of Relative Risk to Public Health from Foodborne Listeria Monocytogenes among Selected Categories of Ready–to–Eat Foods.
52. US General Accounting Office (2004). Antibiotic Resistance: Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals.
53. Varma, J. K., K. D. Greene, et al. (2003). “An outbreak of Escherichia coli O157 infection following exposure to a contaminated building”, Journal of the American Medical Association 290(20): 2709–12.
54. Villar, R. G., M. D. Macek, et al. (1999). “Investigation of multidrug–resistant Salmonella serotype typhimurium DT104 infections linked to raw–milk cheese in Washington State, Journal of the American Medical Association 281(19): 1811–6.
55. Wells, J. G., B. R. Davis, et al. (1983). “Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype”, Journal of Clinical Microbiology 18(3): 512–20.
56. World Trade Organization (2004). World Trade Report 2004: Trade and Trade Policy Developments.
57. Breiman, R. F., M. R. Evans, et al. (2003). “Role of China in the quest to define and control severe acute respiratory syndrome”, Emerging Infectious Diseases 9(9): 1037–41.
58. Capua, I. and D. J. Alexander (2002). “Avian influenza and human health”, Acta Tropica 83(1): 1–6.
59. Centers for Disease Control and Prevention (2005). “Threat to Public Health from Influenza A(H2N2) is Low”, available at CDC website.
60. Centers for Disease Control and Prevention (2005). Information About Influenza Pandemics, http://www.cdc.gov.
61. Centers for Disease Control and Prevention (1995). “Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992–1995”, MMWR Morbidity and Mortality Weekly Report 44(8): 137–40.
62. Claas, E. C., A. D. Osterhaus, et al. (1998). “Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus”, Lancet 351(9101): 472–7.
63. Food and Agriculture Organization of the United Nations (2004). Avian Influenza: Stop the Risk for Humans and Animals at Source.
64. Fritz, C. L., D. T. Dennis, et al. (1996). “Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases”, Emerging Infectious Diseases 2(1): 30–6.
65. Gamblin, S. J., L. F. Haire, et al. (2004). “The structure and receptor binding properties of the 1918 influenza hemagglutinin”, Science 303(5665): 1838–42.
66. Glezen, W. P. (1996). “Emerging infections: pandemic influenza”, Epidemiology Reviews 18(1): 64–76.
67. Hai-yan, L., Y. Kang-zhen, et al. (2004). “Isolation and characterisation of H5N1 and H9N2 influenza viruses from pigs in China”, Chinese Journal of Preventive Veterinary Medicine 26(1).
68. Horimoto, T. and Y. Kawaoka (2001). “Pandemic threat posed by avian influenza A viruses”, Clinical Microbiology Reviews 14(1): 129–49.
69. Kaiser Commission on Medicaid and the Uninsured (2004). The Cost of Care for the Uninsured: What Do We Spend, Who Pays, and What Would Full Coverage Add to Medical Spending?, Washington, D.C., Kaiser Foundation.
70. Leder, K. and D. Newman (2005). “Respiratory infections during air travel”, Internal Medicine Journal 35(1): 50–5.
71. Lederberg, J., R. E. Shope, et al. (eds) (1992). Emerging Infections: Microbial Threats to Health in the United States, Institute of Medicine, National Academy Press.
72. Lee, L. (2004). “The current state of public health in China”, Annual Review of Public Health 25: 327–39.
73. Mandell, G., J. Bennett, et al. (2000). Principles and Practice of Infectious Diseases, Churchill Livingstone, pp. 1823–34.
74. Mangili, A. and M. A. Gendreau (2005). “Transmission of infectious diseases during commercial air travel”, Lancet 365(9463): 989–96.
75. Miller, J. M., T. W. Tam, et al. (2000). “Cruise ships: high–risk passengers and the global spread of new influenza viruses”, Clinical Infectious Diseases 31(2): 433–8.
76. Moser, M. R., T. R. Bender, et al. (1979). “An outbreak of influenza aboard a commercial airliner”, American Journal of Epidemiology 110(1): 1–6.
77. Naik, G. and J. Hookway (2005). “Demand, Cost for Avian–Flu Drug Could Leave Neediest With Least”, Wall Street Journal, 18 May, p. 1.
78. Ninomiya, A., A. Takada, et al. (2002). “Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China”, Veterinary Microbiology 88(2): 107–14.
79. Olsen, S. J., H. L. Chang, et al. (2003). “Transmission of the severe acute respiratory syndrome on aircraft”, New England Journal of Medicine 349(25): 2416–22.
80. Reuters (2003). “Bird Flu Spreads in Europe, Human Health Concerns”, ProMED– mail, 18 April.
81. Schlagenhauf, P., M. Funk, et al. (2004). “Focus on cruise ship travel”, Journal of Travel Medicine 11(3): 191–3.
82. Schuettler, D. (2005). “Bird flu experts urge wider duck cull in Vietnam”, Reuters, 19 April.
83. Shortridge, K. F. (2003). “Severe acute respiratory syndrome and influenza: virus incursions from southern China”, American Journal of Respiratory and Critical Care Medicine 168(12): 1416–20.
84. Shortridge, K. F., J. S. Peiris, et al. (2003). “The next influenza pandemic: lessons from Hong Kong”, Journal of Applied Microbiology 94 Suppl: 70S–79S.
85. Smolinski, M. S., M. A. Hamburg, et al. (eds) (2003). Microbial Threats to Health: Emergence, Detection, and Response, Institute of Medicine.
86. Stephenson, I., K. G. Nicholson, et al. (2004). “Confronting the avian influenza threat: vaccine development for a potential pandemic”, Lancet Infectious Diseases 4(8): 499–509.
87. Swayne, D. E. and D. J. King (2003). “Avian influenza and Newcastle disease”, Journal of the American Veterinary Medicine Association 222(11): 1534–40.
88. Uyeki, T. M., S. B. Zane, et al. 2003. “Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory”, Clinical Infectious Diseases 36(9): 1095–102.
89. Vietnam News Brief Service (2004). “Viet Nam: deaths of 5 children attributed to avian influenza H5 virus”, 10 September.
90. Widdowson, M. A., E. H. Cramer, et al. (2004). “Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus – United States, 2002”, Journal of Infectious Diseases 190(1): 27–36.
91. World Health Organization, WHO Global Influenza Programme.
92. World Health Organization (2005). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) since 28 January 2004.
93. World Health Organization (2004). “Avian influenza – update: implications of H5N1 infections in pigs in China”, 25 August.
94. Alper, T., D. A. Haig, et al. (1966). “The exceptionally small size of the scrapie agent”, Biochemical and Biophysical Research Communications 22(3): 278–84.
95. Beisel, C. E. and D. M. Morens (2004). “Variant Creutzfeldt–Jakob disease and the acquired and transmissible spongiform encephalopathies”, Clinical Infectious Diseases 38(5): 697–704.
96. Centers for Disease Control and Prevention (1982). “Update on acquired immune deficiency syndrome (AIDS) among patients with hemophilia A”, MMWR Morbidity and Mortality Weekly Report 31(48): 644–6, 652.
97. Ghani, A. C., N. M. Ferguson, et al. (2003). “Factors determining the pattern of the variant Creutzfeldt–Jakob disease (vCJD) epidemic in the UK”, Proceedings of the Royal Society of London, Series B (Biological) 270(1516): 689–98.
98. Hillier, C. E. and R. L. Salmon (2000). “Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt–Jakob disease?”, Quarterly Journal of Medicine 93(9): 617–31.
99. Institute of Medicine (1995). “HIV and the blood supply: an analysis of crisis decisionmaking”, Committee to Study HIV Transmission Through Blood and Blood Products, eds L. Leveton, H. Sox and M. Stoto, Washington, D.C., Institute of Medicine, National Academy Press.
100. Krever Commission (1997). Commission of Inquiry on the Blood System in Canada.
101. Supervie, V. and D. Costagliola (2004). “The unrecognised French BSE epidemic”, Veterinary Research 35(3): 349–62.
102. Varghese, B., J. E. Maher, et al. (2002). “Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use”, Sexually Transmitted Diseases 29(1): 38–43.
103. Volkow, P. and C. Del Rio (2005). “Paid donation and plasma trade: unrecognized forces that drive the AIDS epidemic in developing countries”, International Journal of STD and AIDS 16(1): 5–8.
104. Wells, G. A., A. C. Scott, et al. (1987). “A novel progressive spongiform encephalopathy in cattle”, Veterinary Record 121(18): 419–20.
105. Bolton, J. R., Undersecretary for Arms Control and International Security (2002). The US Position on the Biological Weapons Convention: Combating the BW Threat, Tokyo America Center, Tokyo, Japan, US Department of State.
106. British Medical Association (2004). Biotechnology, Weapons and Humanity.
107. Centers for Disease Control and Prevention (2003). “Nicotine poisoning after ingestion of contaminated ground beef – Michigan, 2003”, MMWR Morbidity and Mortality Weekly Report 52(18): 413–6.
108. Chaffee, M., C. Conway-Welch, et al. (2001). “Bioterrorism in the United States: take it seriously”, American Journal of Nursing 101(11): 59, 61.
109. Chalk, P. (2004a). “The bio-terrorist threat to agricultural livestock and produce”, The Office of Science and Technology Policy Blue Ribbon Panel on the Threat of Biological Terrorism Directed Against Livestock, RAND Corporation.
110. Chalk, P. (2004b). Hitting America's Soft Underbelly: The Potential Threat of Deliberate Biological Attacks Against the US Agricultural and Food Industry, RAND National Defense Institute.
111. Christopher, G. W., T. J. Cieslak, et al. (1997). “Biological warfare. A historical perspective”, Journal of the American Medical Association 278(5): 412–7.
112. Council of State and Territorial Epidemiologists (2004). National Assessment of Epidemiologic Capacity: Findings and Recommendations.
113. Cupp, O. S., D. E. Walker, et al. (2004). “Agroterrorism in the US: key security challenge for the 21st century”, Biosecurity and Bioterrorism 2(2): 97–105.
114. Franz, D. R. (2004). “Threats and Risks to US Agriculture: An Overview”, The Office of Science and Technology Policy Blue Ribbon Panel on the Threat of Biological Terrorism Directed Against Livestock, RAND Corporation.
115. Gips, M. (2003). “The first link in the food chain”, Security Management Online, Security Management Magazine.
116. Inglesby, T. V., R. Grossman, et al. (2001). “A plague on your city: observations from TOPOFF”, Clinical Infectious Diseases 32(3): 436–45.
117. Institute of Medicine (2001). Biological Threats and Terrorism: Assessing the Science and Response Capabilities, National Academy Press.
118. Knobler, S., A. Mahmoud, et al. (eds) (2001). Biological Threats and Terrorism: Assessing the Science and Response Capabilities, Institute of Medicine.
119. North Atlantic Treaty Organization (1992). NATO Handbook on the Medical Aspects of NBC Defensive Operations, AMedP-6(B), Part II, Biological.
120. O’Toole, T., M. Mair, et al. (2002). “Shining light on ‘Dark Winter’”, Clinical Infectious Diseases 34(7): 972–83.
121. Office of the Surgeon General (1997). “Medical aspects of chemical and biological warfare”, Textbook of Military Medicine, eds F. R. Sidell, E. T. Takafuji and D. R. Franz, TMM Publications. Part I.
122. Pear, R. (2004). “US Health Chief, Stepping Down, Issues Warning”, The New York Times, December 4th.
123. Potter, W. C. (2004). Prospects for International Cooperation on Biological Security. PIR Center Conference, Moscow.
124. Stith Butler, A., A. Panzer, et al. (eds) (2003). Preparing for the Psychological Consequences of Terrorism: A Public Health Strategy, Institute of Medicine.
125. Turnbull, W., and P. Abhayaratne (2003). 2002 WMD Terrorism Chronology: Incidents Involving Sub-National Actors and Chemical, Biological, Radiological, and Nuclear Materials, Monterey Institute of International Studies.
126. US Food and Drug Administration (2004). “Agencies team up to protect food supply”, FDA Consumer 38(2): 28–9.
127. US General Accounting Office (2003). Bioterrorism: A Threat to Agriculture and the Food Supply.
128. US Government Accountability Office (2005). Homeland Security: Much Is Being Done to Protect Agriculture from a Terrorist Attack, but Important Challenges Remain.
129. Venkatesh, S. and Z. A. Memish (2003). “Bioterrorism – a new challenge for public health”, International Journal of Antimicrobial Agents 21(2): 200–6.
130. World Health Organization (2004). Public Health Response to Biological and Chemical Weapons: WHO Guidance.
131. Animal Health Institute (2002). Antibiotic Use in Animals: The Facts, http://www.ahi.org/mediaCenter/mediaKit/antibUseAnimals.asp.
132. Boneva, R. S. and T. M. Folks (2004). “Xenotransplantation and risks of zoonotic infections”, Annals of Medicine 36(7): 504–17.
133. Centers for Disease Control and Prevention (1993). “Creutzfeldt–Jakob disease in patients who received a cadaveric dura mater graft – Spain, 1985–1992”, MMWR Morbidity and Mortality Weekly Report 42(28): 560–3.
134. Centers for Disease Control and Prevention (2003). “Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts – Japan, 1979–2003”, MMWR Morbidity and Mortality Weekly Report 52(48): 1179–81.
135. Centers for Disease Control and Prevention (2005). Recent Avian Influenza Outbreaks in Asia, May.
136. Dowell, S. F., C. G. Whitney, et al. (2003). “Seasonal patterns of invasive pneumococcal disease”, Emerging Infectious Diseases 9(5): 573–9.
137. Ewald, P. M. (1996). Evolution of Infectious Diseases, Oxford University Press.
138. Fidler, D. P. (1999). “Legal challenges posed by the use of antimicrobials in food animal production”, Microbes and Infection 1(1): 29–38.
139. Fishman, J. A. and C. Patience (2004). “Xenotransplantation: infectious risk revisited”, American Journal of Transplant 4(9): 1383–90.
140. Food and Agriculture Organization of the United Nations (2004). Avian Influenza: Stop the Risk for Humans and Animals at Source.
141. Lancaster, J. (2004). “Surgeries, side trips for ‘medical tourists’”, The Washington Post, A1, October 21st.
142. Levy, S. B. (2002). “The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance”, Journal of Antimicrobial Chemotherapy 49(1): 25–30.
143. Sipress, A. (2005). “Bird flu adds new danger to bloody game: cockfighting among Asian customs that put humans at risk”, The Washington Post, A16, April 14th.
144. Slingenbergh, J. I., M. Gilbert, et al. (2004). “Ecological sources of zoonotic diseases”, Revue scientifique et technique 23(2): 467–84.
145. US General Accounting Office (2004). Antibiotic Resistance: Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals.
146. Witte, W. (2000). “Selective pressure by antibiotic use in livestock”, International Journal of Antimicrobial Agents 16 Suppl 1: S19–24.
147. World Health Organization (2001). Use of Antimicrobials Outside Human Medicine, WHO.
148. World Health Organization (2002). Implementation Workshop on the WHO Global Strategy for Containment of Antimicrobial Resistance, WHO.
149. Barcos, L. O. (2001). “Recent developments in animal identification and the traceability of animal products in international trade”, Revue scientifique et technique 20(2): 640–51.
150. Caporale, V., A. Giovannini, et al. (2001). “Importance of the traceability of animals and animal products in epidemiology”, Revue scientifique et technique 20(2): 372–8.
151. Centers for Disease Control and Prevention (2005). “Escherichia coli O157:H7 infections associated with ground beef from a U.S. military installation – Okinawa, Japan, February 2004”, MMWR Morbidity and Mortality Weekly Report 54(2): 40–2.
152. Jones, T. F., B. Imhoff, et al. (2004). “Limitations to successful investigation and reporting of foodborne outbreaks: an analysis of foodborne disease outbreaks in FoodNet catchment areas, 1998–1999”, Clinical Infectious Diseases 38 Suppl 3: S297–302.
153. Killalea, D., L. R. Ward, et al. (1996). “International epidemiological and microbiological study of outbreak of Salmonella agona infection from a ready to eat savoury snack – I: England and Wales and the United States”, British Medical Journal 313(7065): 1105–7.
154. Lober, W. B., B. T. Karras, et al. (2002). “Roundtable on bioterrorism detection: information system-based surveillance”, Journal of the American Medical Informatics Association 9(2): 105–115.
155. Mahon, B. E., A. Ponka, et al. (1997). “An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds”, Journal of Infectious Diseases 175(4): 876–82.
156. Pettitt, R. G. (2001). “Traceability in the food animal industry and supermarket chains”, Revue scientifique et technique 20(2): 584–97.
157. US Food and Drug Administration (2004). Fact Sheet on FDA's New Food Bioterrorism Regulation: Establishment and Maintenance of Records.
158. US General Accounting Office (1999). “Emerging Infectious Diseases: National Surveillance System Could Be Strengthened”, Testimony before the Subcommittee on Public Health, Committee on Health, Education, Labor and Pensions, US Senate.
159. US Government Accountability Office (2004a). Food Safety: USDA and FDA Need to Better Ensure Prompt and Complete Recalls of Potentially Unsafe Food.
160. US Government Accountability Office (2004b). Infectious Diseases: Review of State and Federal Disease Surveillance Efforts.
161. Van Pelt, W., D. J. Mevius, et al. (2004). “A large increase of Salmonella infections in 2003 in the Netherlands: hot summer or side effect of the avian influenza outbreak?”, Euro Surveillance 9(7).
162. Werber, D., J. Dreesman, et al. (2005). “International outbreak of Salmonella Oranienburg due to German chocolate”, BMC Infectious Diseases 5(1): 7.
163. Brown, M. (2000). Administrator, UNDP, Address to Ministers of Trade of Least Developed Countries, Bangkok, Thailand.
164. Calvin, L. (2003). “Produce, food safety, and international trade: response to US foodborne illness outbreaks associated with imported produce”, Chapter 5 in J. C. Buzby (ed.) International Trade and Food Safety: Economic Theory and Case Studies, Economic Research Service, US Department of Agriculture.
165. Cash, J. and J. Kastner (2004). SPS Notifications Tool, Kansas State University.
166. CBC News Online (2003). “Toronto mayor rails against WHO warning”, April 24th.
167. Comba, P. and R. Pasetto (2004). “The precautionary principle: scientific evidence and decision processes”, Epidemiologia e preventzione 28(1): 41–5.
168. Conzaniga, A. (2002). “GATS and trade in health services” in N. Drager and C. Viera, Trade in Health Services, World Health Organization.
169. Cunningham, E. P. (2003). After BSE – A Future for the European Livestock Sector, European Association for Animal Production, Wageningen Academic Publishers.
170. Goldstein, B. and R. S. Carruth (2004). “The precautionary principle and/or risk assessment in World Trade Organization decisions: a possible role for risk perception”, Risk Analysis 24(2): 491–9.
171. Lang, T. (1999). “Diet, health and globalization: five key questions”, Proceedings of the Nutrition Society 58(2): 335–43.
172. McCrea, D. (1997). “Codex Alimentarius – in the consumer interest?”, Consumer Policy Review 7(4): 132–8.
173. Morse, S. S. (1995). “Factors in the emergence of infectious diseases”, Emerging Infectious Diseases 1(1): 7–15.
174. Oliveira, M. A., J. A. Bermudez, et al. (2004). “Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?”, Bulletin of the World Health Organization 82(11): 815–21.
175. Public Citizen (2003). “The WTO comes to dinner: US implementation of trade rules bypasses food safety requirements”, July.
176. Silverglade, B. A. (2000). “The WTO agreement on sanitary and phytosanitary measures: weakening food safety regulations to facilitate trade?”, Food and Drug Law Journal 55(4): 517–24.
177. Vose, D., J. Acar, et al. (2001). “Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin”, Revue scientifique et technique 20(3): 811–27.
178. World Bank Group (2003). World Bank Responds to SARS.
179. World Health Organization (1998). Global Infectious Disease Surveillance.
180. World Health Organization (2003). WHO Extends its SARS–related Travel Advice to Beijing and Shanxi Province in China and to Toronto, Canada.
181. World Health Organization (2005). International Health Regulations.
182. World Health Organization Regional Committee for the Western Pacific (1998). Fifty Years of WHO in the Western Pacific Region.
183. World Trade Organization (2005). Review of the Operation and Implementation of the SPS Agreement.
184. World Trade Organization Committee on Technical Barriers to Trade (2005). Transparency Requirements and Procedures.
185. World Trade Organization Council for Trade in Services (1999). “Article VI.4 of the GATS: Disciplines on domestic regulation applicable to all services”, Note by the Secretariat, 1 March 1999.
186. Anderson, R. M. and R. M. May (1991). Infectious Diseases of Humans: Dynamics and Control, Oxford, Oxford University Press.
187. Arkless, D. (2005). Report on Business and HIV/AIDS, World Economic Forum, Davos, Switzerland.
188. Baumes, H. and S. Ramsey (2005). “Mad cow loose in the United States?”, Global Insight, http://www.globalinsight.com/Perspective/PerspectiveDetail724.htm.
189. Donegan, E., M. Stuart, et al. (1990). “Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations”, Annals of Internal Medicine 113(10): 733–9.
190. Henderson, D. A., T. V. Inglesby, et al. (1999). “Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense”, Journal of the American Medical Association 281(22): 2127–37.
191. Hufnagel, L., D. Brockmann, et al. (2004). “Forecast and control of epidemics in a globalized world”, Proceedings of the National Academy of Sciences of the USA 101(42): 15124–9.
192. Jones, T. F. and W. Schaffner (2003). “Salmonella in imported mangos: shoeleather and contemporary epidemiologic techniques together meet the challenge”, Clinical Infectious Diseases 37(12): 1591–2.
193. Kennedy, M. (2005). “India and its medical outsourcing industry” in Marketplace, National Public Radio, 5 April.
194. Kimball, A. M. and M. Thant (1996). “A role for businesses in HIV prevention in Asia”, Lancet 347(9016): 1670–2.
195. Kingdon, J. W. (1995). Agendas, Alternatives, and Public Policies, New York, Addison-Wesley Longman.
196. Klausner, R. D., A. S. Fauci, et al. (2003). “Medicine – the need for a global HIV vaccine enterprise”, Science 300(5628): 2036–9.
197. Layne, S. P., T. J. Beugelsdijk, et al. (2001). “A global lab against influenza”, Science 293(5536): 1729.
198. McMichael, A. (1993). Planetary Overload: Global Environmental Change and the Health of the Human Species, Cambridge University Press.
199. Potter, J. D. (2004). “Toward the last cohort”, Cancer Epidemiology Biomarkers and Prevention 13(6): 895–7.
200. Sachs, J. (2005). The End of Poverty: Economic Possibilities for Our Time, New York, Penguin Press.
201. Smith, R. D., R. Beaglehole, D. Woodward and N. Drager (2003). Global Public Goods for Health: A Health, Economic and Public Health Perspective. Oxford University Press.
202. Smith, R. D., D. Woodward, et al. (2004). “Communicable disease control: a ‘global public good’ perspective”, Health Policy and Planning 19(5): 271–8.
203. Stiglitz, J. E. (2003). Globalization and Its Discontents, W. W. Norton & Company.
204. UNICEF and World Health Organization (2002). Meeting the MDG Drinking Water and Sanitation Target: A Mid-term Assessment of Progress.
205. Varghese, B., J. E. Maher, et al. (2002). “Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use”, Sexually Transmitted Diseases 29(1): 38–43.
206. World Health Organization (2000). Global Water Supply and Sanitation Assessment, 2000 Report.
207. World Health Organization (2005). International Health Regulations.